NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for prochlorperazine


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Alexza Appoints Andrew L. Busser to Board of Directors
2009 OCT 5 ... Alexza has completed an end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine) and has completed two Phase 2 studies with AZ-104 (Staccato loxapine, low-dose). Both ...
Subject: Alexza Pharmaceuticals, Inc.
Price: $3.00
*
Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
2009 MAR 23 ... to repurchase all rights to this product candidate -- AZ-001 (Staccato prochlorperazine). Alexza is developing AZ-001 to treat patients suffering from acute ...
Subject: Alexza Pharmaceuticals, Inc.
Price: $3.00
*
James Cook University publishes research in pharmaceuticals
2009 MAR 16 ... Researchers detail in 'Prochlorperazine tablets repackaged into dose administration aids: can the patient be assured of ...
Subject: Pharmaceuticals
Price: $3.00
*
New schizophrenia findings from University of Toronto published
2009 JUL 13 ... first-generation (conventional) antipsychotics (e.g., promethazine, chlorpromazine, prochlorperazine, haloperidol, perphenazine, trifluoperazine, loxapine, thioridazine, flupenthixol, ...
Subject: Schizophrenia
Price: $3.00
*
Reports from Tufts University, Medical Department advance knowledge in pharmacology and experimental therapeutics
2009 JAN 13 ... Niacin increases plasma PGD(2) and serotonin in a rat model of flush. The phenothiazine prochlorperazine, the H-1, serotonin receptor antagonist cyproheptadine, and the specific serotonin ...
Subject: Pharmacology and Experimental Therapeutics
Price: $3.00
*
Research from J. Cotter and co-authors reveals new findings on vomiting
2009 JUN 15 ... that cannabinoids are more effective than placebo and comparable to aritiemetics Such as prochlorperazine and ondansetron for CINV Implications for Nursing: Nurses should feel supported by the ...
Subject: Vomiting
Price: $3.00
*
Research on ethnology detailed by scientists at Brown University
2009 JAN 13 ... OX4 2DQ, Oxon, England. Keywords: United States, Box, Life Sciences, Prochlorperazine, Compro, Pharmaceuticals, Drugs, Therapy, Treatment, Ethnology, Brown University. ...
Subject: Ethnology
Price: $3.00
*
Research on pharmacokinetics detailed by scientists at Northwestern University
2009 FEB 16 ... systemic drug absorption." "We developed a pharmacokinetic model of prochlorperazine, administered by inhalation and as a rapid intravenous infusion, and we determined ...
Subject: Pharmacokinetics
Price: $3.00
*
Studies from Cincinnati Children's Hospital describe new findings in headache and migraine
2009 MAY 11 ... a total of 6 episodes of acute confusional migraine where the symptoms resolved with prochlorperazine with variable success," wrote R. Khatri and colleagues, Cincinnati Children's ...
Subject: Headache and Migraine
Price: $3.00
*
Studies from Haukeland University, Department of Surgery further understanding of adenocarcinoma epidemiology
2009 MAR 16 ... Epidemiology, Gastroenterology, Microsurgery, Oncology, Pathology, Pharmaceuticals, Prochlorperazine, Rectal Cancer, Rectal Carcinoma, Surgery, Therapy, Treatment. This ...
Subject: Adenocarcinoma Epidemiology
Price: $3.00
*
Studies from Loyola University, Department of Anesthesiology have provided new information about vomiting therapy
2009 FEB 2 ... 'Patient-controlled analgesia combined with either ondansetron or ondansetron plus prochlorperazine for control of pain and nausea and vomiting in patients undergoing abdominal ...
Subject: Vomiting Therapy
Price: $3.00
*
Alexza Completes Enrollment in Second Phase 3 Clinical Trial With AZ-004 (Staccato(R) Loxapine) for Acute Agitation
2008 OCT 27 ... Alexza recently completed an end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine) and the Company believes it has a clear understanding of the NDA requirements for this ...
Subject: Bipolar Disorder
Price: $3.00
*
Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
2008 AUG 18 ... to repurchase all rights to this product candidate. -- AZ-001 (Staccato prochlorperazine). Alexza is developing AZ-001 to treat patients suffering from acute migraine headaches. ...
Subject: Bipolar Disorder
Price: $3.00
*
Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
2008 NOV 17 ... to repurchase all rights to this product candidate. -- AZ-001 (Staccato prochlorperazine). Alexza is developing AZ-001 to treat patients suffering from acute migraine headaches. ...
Subject: Alexza Pharmaceuticals, Inc.
Price: $3.00
*
Alexza's Corporate Presentation to be Webcast at the Third Annual JMP Securities Healthcare Focus
2008 OCT 13 ... trial. A second Phase 3 clinical trial was initiated in July 2008. AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches has completed Phase 2 testing, and AZ-104 ...
Subject: Drug Development
Price: $3.00
*
CADENS IMAGING introduces its portable and fully automated CT colonography product, this week at RSNA
2008 DEC 15 ... medical practice says Hugo Douville, CEO. Keywords: Cadens Imaging, Prochlorperazine, Compro, Pharmaceuticals, Drugs, Therapy, Treatment. This article was ...
Subject: Cadens Imaging
Price: $3.00
*
Findings from J.E. Callan and co-authors broaden understanding of headache and migraine
2008 DEC 4 ... in undifferentiated headache. We hypothesized that promethazine would be superior to prochlorperazine in the treatment of headache. We conducted a prospective, double-blinded, randomized, ...
Subject: Nursing Ethics
Price: $3.00
*
New non-hodgkin lymphoma findings from T.A. Lahti and co-authors described
2008 DEC 15 ... Cancer, Compro, Drugs, Hematology, Non-Hodgkin Lymphoma, Oncology, Pharmaceuticals, Prochlorperazine, Therapy, Treatment. This article was prepared by Biotech Business Week ...
Subject: Non-Hodgkin Lymphoma
Price: $3.00
*
Research from University of Bergen, Department of Biomedicine in biomedicine provides new insights
2008 DEC 29 ... in the Saudi Medical Journal, "To compare the effects of chlorpromazine (CPZ), prochlorperazine (PCP), trifluoperazine (TFP), clozapine (CLO), haloperidol (HPD), quetiapine (QTP), ...
Subject: Biomedicine
Price: $3.00
*
Study results from College of Medicine broaden understanding of headache and migraine
2008 NOV 24 ... According to a study from the United States, "We compare prochlorperazine 10 mg intravenously versus metoclopramide 20 mg intravenously for the emergency ...
Subject: Headache and Migraine
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login